Article ID Journal Published Year Pages File Type
4021218 Journal of Cataract & Refractive Surgery 2007 7 Pages PDF
Abstract
Nepafenac showed significantly greater ocular bioavailability and amfenac demonstrated greater potency at COX-2 inhibition than ketorolac or bromfenac.
Related Topics
Health Sciences Medicine and Dentistry Ophthalmology
Preview
In vivo pharmacokinetics and in vitro pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac
Authors
, , , , ,